FIELD: pharmacology.
SUBSTANCE: invention relates to medicine, particularly to pharmacology, and concerns the use of low-molecular mimetic neurotrophin-3 hexamethylenediamide bis-(N-monosuccinyl-L-asparaginyl-L-asparagine) (GTS-301) as an agent for reducing pain response and restoring tactile pain sensitivity to normal physiological values in peripheral neuropathy.
EFFECT: using the invention enables reducing pain response effectively and recovering tactile pain sensitivity to normal physiological values in peripheral neuropathy.
1 cl, 4 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIMERIC DIPEPTIDE MIMETICS OF NEUROTROFIN-3 | 2022 |
|
RU2800369C1 |
| LOW MOLECULAR WEIGHT MIMETIC OF BRAIN NEUROTROPHIC FACTOR WITH ANALGESIC, ANXIOLYTIC AND ANTIADDICTIVE EFFECTS | 2020 |
|
RU2759023C2 |
| COMBINATION , CONTAINING HERB COMBINATION EXTRACT, FOR PREVENTION OR TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY | 2011 |
|
RU2566721C2 |
| MEANS FOR OPIOID ABSTINENCE SYNDROME ARRESTING | 2017 |
|
RU2643588C1 |
| SMALL MOLECULES WITH NGF-LIKE ACTIVITY AND ANTIDIABETIC PROPERTIES | 2013 |
|
RU2613314C2 |
| DIMERIC DIPEPTIDE MIMETIC BDNF AS AGENT FOR TREATING AND PREVENTING OPIOID ADDICTION | 2023 |
|
RU2823374C1 |
| ANALGESIC AGENT FOR VISCERAL PAIN MANAGEMENT | 2010 |
|
RU2429874C1 |
| MEDICATION FOR PREVENTION AND CORRECTION OF DIABETES MANIFESTATIONS | 2012 |
|
RU2563234C2 |
| DRUG FOR PREVENTION AND TREATMENT OF DIABETES | 2013 |
|
RU2597848C2 |
| PEPTIDE AGENT POSSESSING ANALGESIC ANTI-INFLAMMATORY ACTION, AND BASED DOSAGE FORMS | 2012 |
|
RU2528094C2 |
